July 24, 2026
A Delaware bankruptcy judge on Friday conditionally approved the disclosure statement for microbiome treatment developer Finch Therapeutics' Chapter 11 plan, allowing it to solicit creditor votes.
July 08, 2026
Microbiome treatment developer Finch Therapeutics will ask a Delaware bankruptcy judge to approve a Chapter 11 plan that would allow it to sell all assets to a rival company and exit bankruptcy. Here's a look at the liquidating plan it is hoping to get confirmed.
March 25, 2026
A team of attorneys from Chipman Brown Cicero & Cole LLP and Ropes & Gray LLP is steering the Chapter 11 case of Finch Therapeutics, a company that develops treatments to improve the health of the body's microbiome.
March 25, 2026
Microbiome treatment developer Finch Therapeutics told a Delaware bankruptcy judge Wednesday that its lack of income or ability to collect on a patent judgment justified its Chapter 11 filing despite a lack of secured debts.
March 24, 2026
The maker of spandex is looking to swap its debt for equity in Chapter 11, a longtime book distributor plans to finish winding down operations while its bankruptcy keeps an automatic stay on litigation, and a microbiome treatment developer wants to sell its assets in bankruptcy.
March 23, 2026
A company that develops treatments to improve the health of the body's microbiome sought Chapter 11 protection, saying it had never generated a positive cash flow and faces unresolved litigation and a burdensome lease.